Investigating the effect of bromelain in preventing mucositis caused by 5 fluorouracil (5-FU( in patients with gastrointestinal cancer
Not Applicable
Recruiting
- Conditions
- patients with gastrointestinal cancer.Malignant neoplasm of ill-defined sites within the digestive systemC26.9
- Registration Number
- IRCT20240601061970N1
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with cancer of the digestive system who take fu5-bolus (within half an hour)take
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method